Dr. Andrew J. Sulich, MD

Dr. Sulich practices at Shores Rheumatology in Saint Clair Shores, Michigan.

Dr. Sulich's NPI, 1508946385, was assigned on October 16, 2006. Dr. Sulich holds Michigan license AS048976.

Dr. Sulich's primary practice is Shores Rheumatology, at 29200 Harper Ave, Saint Clair Shores, MI 48081-1274. The practice phone is (586) 777-7577.

Dr. Sulich's primary practice is Shores Rheumatology in Saint Clair Shores, Michigan. Dr. Sulich is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Shores Rheumatology. Dmand AI also links Dr. Sulich to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sulich practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Sulich's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Sulich is licensed in Michigan.

CMS data shows 190,737 Medicare services from Dr. Sulich across 21 procedure codes in 2024, for 466 Medicare patients. Medicare paid $1,446,872 for them. Every service was in an office.

CMS counts 466 Medicare patients who saw Dr. Sulich in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have arthritis, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sulich's median patient age at 68, with 74% women.

In 2024, Dr. Sulich wrote 5,002 Medicare Part D claims for 644 patients. 87% of them were for generic drugs. CMS names the drug for 4,811 of them, across 59 drugs with 11 or more claims each, at $3,702,033 in total drug cost. In 2023, CMS named 4,569 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Sulich for performance year 2024, reported as part of a group. Dr. Sulich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sulich as offering telehealth.

Dmand AI links Dr. Sulich to 2 clinical trials. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Sulich that name 2 trials.

CMS Open Payments shows 5,657 general payments to Dr. Sulich from 61 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Celgene Corporation paid the most, $728,407. It also lists 6 research payments totaling $952 from 2017 to 2022, naming 2 clinical trials.